Skip to content

Clinical Assessment of a Daily Disposable Soft Silicone Hydrogel Contact Lens

Clinical Assessment of a Daily Disposable Soft Silicone Hydrogel Contact Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06044948
Enrollment
97
Registered
2023-09-21
Start date
2023-10-13
Completion date
2023-11-08
Last updated
2024-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Errors

Keywords

Contact Lenses

Brief summary

The purpose of this study is to assess the clinical performance of DAILIES TOTAL1® spherical soft contact lenses over approximately 1 week of daily wear.

Detailed description

Subjects will be expected to attend 2 visits (Visit 1 Screen/Baseline/ Dispense; and Visit 2 Week 1 Follow-up/ Exit). The total duration of a subject's participation in the study as well as exposure to the contact lenses will be approximately 1 week (6-8 days of contact lens wear).

Interventions

Daily disposable, silicone hydrogel spherical contact lenses

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

In this single arm study, the subject will be masked to the lens type.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Key Inclusion Criteria: * Current wearer of commercial spherical soft contact lenses in both eyes with at least 3 months of wearing experience, with a minimum wearing time of 5 days per week and 10 hours per day; * Manifest cylinder less than or equal to 0.75 diopter (D) in each eye; * Best corrected distance visual acuity better than or equal to 20/25 (Snellen) in each eye. Key

Exclusion criteria

* Current or prior habitual DAILIES TOTAL1 soft contact lens wear in the past 3 months prior to consent; * Monovision contact lens wear; * Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.

Design outcomes

Primary

MeasureTime frameDescription
Distance VA With Study Lenses at Week 1Week 1Visual acuity (VA) was measured for each eye individually with study lenses on eye using letter charts. VA was recorded in Snellen where 20/20 represents normal distance eyesight and 20/15 represents better than normal eyesight. No hypothesis testing was prespecified for this endpoint.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 6 investigative sites located in 1 country (US).

Pre-assignment details

Of the 97 enrolled, 1 subject was exited as a screen failure prior to being exposed to the product. This reporting group includes all participants who were exposed to the product (96).

Participants by arm

ArmCount
DAILIES TOTAL1
Delefilcon A contact lenses (daily disposable, silicone hydrogel spherical contact lenses) worn in both eyes for the typical number of hours the subject wears his/her habitual contact lenses. The lenses were worn in a daily disposable manner.
96
Total96

Baseline characteristics

CharacteristicDAILIES TOTAL1
Age, Continuous35.9 years
STANDARD_DEVIATION 8.7
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants
Race/Ethnicity, Customized
Asian
1 Participants
Race/Ethnicity, Customized
Black or African American
9 Participants
Race/Ethnicity, Customized
Hispanic or Latino
3 Participants
Race/Ethnicity, Customized
Multi-racial
1 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants
Race/Ethnicity, Customized
Not Hispanic or Latino
93 Participants
Race/Ethnicity, Customized
Other
2 Participants
Race/Ethnicity, Customized
White
83 Participants
Sex: Female, Male
Female
65 Participants
Sex: Female, Male
Male
31 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 960 / 1920 / 96
other
Total, other adverse events
0 / 960 / 1920 / 96
serious
Total, serious adverse events
0 / 960 / 1920 / 96

Outcome results

Primary

Distance VA With Study Lenses at Week 1

Visual acuity (VA) was measured for each eye individually with study lenses on eye using letter charts. VA was recorded in Snellen where 20/20 represents normal distance eyesight and 20/15 represents better than normal eyesight. No hypothesis testing was prespecified for this endpoint.

Time frame: Week 1

Population: The safety analysis set included all subjects/eyes exposed to DAILIES TOTAL1 lenses evaluated in this study.

ArmMeasureGroupValue (NUMBER)
DAILIES TOTAL1Distance VA With Study Lenses at Week 120/1595 eyes
DAILIES TOTAL1Distance VA With Study Lenses at Week 120/2092 eyes
DAILIES TOTAL1Distance VA With Study Lenses at Week 120/255 eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026